financetom
AMPH
financetom
/
Healthcare
/
AMPH
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Amphastar Pharmaceuticals, Inc.AMPH
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.

The company operates through two segments, Finished Pharmaceutical Products and Active Pharmaceutical Ingredient (API).

It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, a low molecular weight heparin to prevent and treat deep vein thrombosis; Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency.

The company also provides Amphadase, a bovine-sourced hyaluronidase injection to absorb and disperse other injected drugs; Epinephrine injection for the emergency treatment of allergic reactions; Lidocaine jelly, an anesthetic product for urological procedures; Lidocaine topical solution for various procedures; Phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products for emergency use in hospital settings; morphine injection for use with patient controlled analgesia pumps; and Lorazepam injection for surgery and medical procedures.

In addition, it offers Neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; Isoproterenol hydrochloride injection for mild or transient episodes of heart block; Ganirelix Acetate injection for the inhibition of premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation; and Vasopressin to increase blood pressure in adults with vasodilatory shock.

Further, the company distributes recombinant human insulin APIs and porcine insulin API. It serves hospitals, care facilities, alternate care sites, clinics, and doctors' offices.

The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.

Latest News >
Stryker Completes Acquisition of French Joint Replacement Firm Serf
Stryker Completes Acquisition of French Joint Replacement Firm Serf
Mar 21, 2024
09:59 AM EDT, 03/21/2024 (MT Newswires) -- Stryker (SYK) said Thursday that it has completed its acquisition of French joint replacement provider Serf. The medical products maker said that Serf's offerings complement its product portfolio and strengthen its presence in France and Europe. Price: 351.55, Change: -1.64, Percent Change: -0.46 ...
The Analyst Verdict: Sprout Social In The Eyes Of 13 Experts
The Analyst Verdict: Sprout Social In The Eyes Of 13 Experts
Mar 21, 2024
Ratings for Sprout Social ( SPT ) were provided by 13 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective. Bullish...
WisdomTree Shareholder ETFS Capital Asks Shareholders to Withhold Votes to Pressure Board Into Review
WisdomTree Shareholder ETFS Capital Asks Shareholders to Withhold Votes to Pressure Board Into Review
Mar 21, 2024
09:57 AM EDT, 03/21/2024 (MT Newswires) -- WisdomTree ( WT ) shareholder ETFS Capital on Thursday urged fellow stockholders to join it in withholding votes from board members at company's upcoming shareholder meeting to ask for a comprehensive review process. The investment company, which holds about 10% state in WisdomTree ( WT ), had written a letter to WisdomTree's (...
US Justice Department to announce antitrust action
US Justice Department to announce antitrust action
Mar 21, 2024
WASHINGTON, March 21 (Reuters) - The U.S. Department of Justice will make an antitrust announcement later on Thursday, it said in a statement without offering any details. Attorney General Merrick Garland, Deputy Attorney General Lisa Monaco and other top department officials will hold an 11 a.m. (1500 GMT) press conference to announce the antitrust action, the department said. On Wednesday,...
Copyright 2023-2025 - www.financetom.com All Rights Reserved